{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:40:00Z","timestamp":1767840000097,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,8,15]],"date-time":"2014-08-15T00:00:00Z","timestamp":1408060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s13277-014-2434-7","type":"journal-article","created":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T23:05:16Z","timestamp":1407971116000},"page":"11359-11366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Molecular regulation of ovarian cancer cell invasion"],"prefix":"10.1007","volume":"35","author":[{"given":"Ningxia","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinmei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,15]]},"reference":[{"key":"2434_CR1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s13224-013-0419-x","volume":"63","author":"DK Dutta","year":"2013","unstructured":"Dutta DK, Dutta I. Origin of ovarian cancer: molecular profiling. J Obstet Gynaecol India. 2013;63:152\u20137.","journal-title":"J Obstet Gynaecol India"},{"key":"2434_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gde.2013.01.004","volume":"23","author":"G Leva Di","year":"2013","unstructured":"Di Leva G, Croce CM. MiRNA profiling of cancer. Curr Opin Genet Dev. 2013;23:3\u201311.","journal-title":"Curr Opin Genet Dev"},{"key":"2434_CR3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.drudis.2012.10.002","volume":"18","author":"DM Pereira","year":"2013","unstructured":"Pereira DM, Rodrigues PM, Borralho PM, Rodrigues CM. Delivering the promise of miRNA cancer therapeutics. Drug Discov Today. 2013;18:282\u20139.","journal-title":"Drug Discov Today"},{"key":"2434_CR4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.canlet.2013.11.004","volume":"344","author":"X Feng","year":"2014","unstructured":"Feng X, Wang Z, Fillmore R, Xi Y. MiR-200, a new star miRNA in human cancer. Cancer Lett. 2014;344:166\u201373.","journal-title":"Cancer Lett"},{"key":"2434_CR5","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.2174\/092986710794182980","volume":"17","author":"AA Shah","year":"2010","unstructured":"Shah AA, Leidinger P, Blin N, Meese E. MiRNA: small molecules as potential novel biomarkers in cancer. Curr Med Chem. 2010;17:4427\u201332.","journal-title":"Curr Med Chem"},{"issue":"Suppl 1","key":"2434_CR6","first-page":"S43","volume":"14","author":"R Jankovic","year":"2009","unstructured":"Jankovic R, Radulovic S, Brankovic-Magic M. SiRNA and miRNA for the treatment of cancer. J Buon. 2009;14 Suppl 1:S43\u20139.","journal-title":"J Buon"},{"key":"2434_CR7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1677\/ERC-10-0148","volume":"18","author":"S Leskela","year":"2011","unstructured":"Leskela S, Leandro-Garcia LJ, Mendiola M, Barriuso J, Inglada-Perez L, Munoz I, et al. The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients. Endocr Relat Cancer. 2011;18:85\u201395.","journal-title":"Endocr Relat Cancer"},{"key":"2434_CR8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ygyno.2009.08.009","volume":"116","author":"A Bendoraite","year":"2010","unstructured":"Bendoraite A, Knouf EC, Garg KS, Parkin RK, Kroh EM, O'Briant KC, et al. Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition. Gynecol Oncol. 2010;116:117\u201325.","journal-title":"Gynecol Oncol"},{"key":"2434_CR9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ygyno.2009.05.022","volume":"114","author":"X Hu","year":"2009","unstructured":"Hu X, Macdonald DM, Huettner PC, Feng Z, El Naqa IM, Schwarz JK, et al. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. Gynecol Oncol. 2009;114:457\u201364.","journal-title":"Gynecol Oncol"},{"key":"2434_CR10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1757-2215-7-12","volume":"7","author":"N Jabbari","year":"2014","unstructured":"Jabbari N, Reavis AN, McDonald JF. Sequence variation among members of the miR-200 microRNA family is correlated with variation in the ability to induce hallmarks of mesenchymal-epithelial transition in ovarian cancer cells. J Ovarian Res. 2014;7:12.","journal-title":"J Ovarian Res"},{"key":"2434_CR11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1479-5876-12-4","volume":"12","author":"M Kobayashi","year":"2014","unstructured":"Kobayashi M, Salomon C, Tapia J, Illanes SE, Mitchell MD, Rice GE. Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200. J Transl Med. 2014;12:4.","journal-title":"J Transl Med"},{"key":"2434_CR12","first-page":"2396","volume":"7","author":"B Schmalfeldt","year":"2001","unstructured":"Schmalfeldt B, Prechtel D, Harting K, Spathe K, Rutke S, Konik E, et al. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res. 2001;7:2396\u2013404.","journal-title":"Clin Cancer Res"},{"key":"2434_CR13","first-page":"233","volume":"54","author":"B Smolarz","year":"2003","unstructured":"Smolarz B, Szyllo K, Romanowicz-Makowska H, Niewiadomski M, Kozlowska E, Kulig A. PCR analysis of matrix metalloproteinase 3 (MMP-3) gene promoter polymorphism in ovarian cancer. Pol J Pathol. 2003;54:233\u20138.","journal-title":"Pol J Pathol"},{"key":"2434_CR14","first-page":"357","volume":"21","author":"K Szyllo","year":"2002","unstructured":"Szyllo K, Smolarz B, Romanowicz-Makowska H, Niewiadomski M, Kozlowska E, Kulig A. The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer. J Exp Clin Cancer Res. 2002;21:357\u201361.","journal-title":"J Exp Clin Cancer Res"},{"key":"2434_CR15","doi-asserted-by":"crossref","first-page":"e42436","DOI":"10.1371\/journal.pone.0042436","volume":"7","author":"JC Cheng","year":"2012","unstructured":"Cheng JC, Auersperg N, Leung PC. TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells. PLoS One. 2012;7:e42436.","journal-title":"PLoS One"},{"key":"2434_CR16","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1038\/onc.2011.484","volume":"31","author":"SM Ahn","year":"2012","unstructured":"Ahn SM, Cha JY, Kim J, Kim D, Trang HT, Kim YM, et al. Smad3 regulates E-cadherin via miRNA-200 pathway. Oncogene. 2012;31:3051\u20139.","journal-title":"Oncogene"},{"key":"2434_CR17","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1038\/onc.2010.172","volume":"29","author":"S Nakahata","year":"2010","unstructured":"Nakahata S, Yamazaki S, Nakauchi H, Morishita K. Downregulation of ZEB1 and overexpression of Smad7 contribute to resistance to TGF-beta1-mediated growth suppression in adult T-cell leukemia\/lymphoma. Oncogene. 2010;29:4157\u201369.","journal-title":"Oncogene"},{"key":"2434_CR18","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1093\/emboj\/cdg225","volume":"22","author":"AA Postigo","year":"2003","unstructured":"Postigo AA. Opposing functions of ZEB proteins in the regulation of the TGFbeta\/BMP signaling pathway. EMBO J. 2003;22:2443\u201352.","journal-title":"EMBO J"},{"key":"2434_CR19","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2337\/db12-1428","volume":"62","author":"X Xiao","year":"2013","unstructured":"Xiao X, Wiersch J, El-Gohary Y, Guo P, Prasadan K, Paredes J, et al. TGFbeta receptor signaling is essential for inflammation-induced but not beta-cell workload-induced beta-cell proliferation. Diabetes. 2013;62:1217\u201326.","journal-title":"Diabetes"},{"key":"2434_CR20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"J Massague","year":"2008","unstructured":"Massague J. TGFbeta in cancer. Cell. 2008;134:215\u201330.","journal-title":"Cell"},{"key":"2434_CR21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/cr.2008.316","volume":"19","author":"D Padua","year":"2009","unstructured":"Padua D, Massague J. Roles of TGFbeta in metastasis. Cell Res. 2009;19:89\u2013102.","journal-title":"Cell Res"},{"key":"2434_CR22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000324949","volume":"170","author":"HY Lan","year":"2011","unstructured":"Lan HY, Chung AC. Transforming growth factor-beta and Smads. Contrib Nephrol. 2011;170:75\u201382.","journal-title":"Contrib Nephrol"},{"key":"2434_CR23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/1471-2164-14-338","volume":"14","author":"DP Tonge","year":"2013","unstructured":"Tonge DP, Tugwood JD, Kelsall J, Gant TW. The role of microRNAs in the pathogenesis of MMPi-induced skin fibrodysplasia. BMC Genomics. 2013;14:338.","journal-title":"BMC Genomics"},{"key":"2434_CR24","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/carcin\/bgs189","volume":"33","author":"O Soubani","year":"2012","unstructured":"Soubani O, Ali AS, Logna F, Ali S, Philip PA, Sarkar FH. Re-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer. Carcinogenesis. 2012;33:1563\u201371.","journal-title":"Carcinogenesis"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2434-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-014-2434-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2434-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:29:50Z","timestamp":1559489390000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-014-2434-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,15]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["2434"],"URL":"https:\/\/doi.org\/10.1007\/s13277-014-2434-7","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,15]]}}}